Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: J Am Pharm Assoc (2003). 2020 Aug 25;60(6):e236–e245. doi: 10.1016/j.japh.2020.08.002

Table 1.

Diagnostic performance characteristics for OTC medications on the EHR medication list (n = 450)

Medications No. active
users
Positive predictive value
% (95% CI)
Negative predictive value
% (95% CI)
Sensitivity
% (95% CI)
Specificity
% (95% CI)
Accuracy
% (95% CI)
Aspirin 173 88.4 (82.3–93.0) 87.8 (83.5–91.3) 79.2 (72.4–85.0) 93.5 (89.9–96.1) 88.0 (84.6–90.9)
NSAIDs 69a 71.4 (44.6–88.6) 93.3 (92.7–93.9) 14.5 (7.2–25.0) 99.5 (98.8–99.9) 93.0 (91.1–94.6)
 Ibuprofen 55 69.2 (41.8–87.6) 90.5 (89.4–91.4) 16.4 (7.8–28.8) 99.1 (97.7–99.8) 88.9 (86.9–92.4)
 Naproxen 14 100 (N/A) 97.1 (96.7–97.5) 7.1 (0.2–33.9) 100 (99.2–100) 97.1 (95.1–98.5)
PPIs 97 69.6 (61.9–76.4) 98.5 (97.7–99.0) 80.4 (71.1–87.8) 97.3 (96.2–98.1) 96.1 (94.9–97.1)
 Omeprazole 84 68.4 (60.3–75.5) 95.2 (92.8–96.8) 79.8 (69.6–87.8) 91.5 (88.2–94.2) 89.3 (86.1–92.0)
 Esomeprazole 8 77.8 (46.1–93.5) 99.8% (98.6–100) 87.5 (47.4–99.7) 99.6 (98.4–100) 99.3 (98.1–99.9)
 Lansoprazole 5 80.0 (35.0–99.5) 99.8 (98.7–100) 80.0 (28.4–99.5) 99.8 (98.8–100) 99.6 (98.4–100)

Abbreviations used: OTC, over-the-counter; EHR, electronic health record; NSAID, nonsteroidal anti-inflammatory drug; N/A, not available; PPI, proton pump inhibitor.

a

Three patients were actively using both ibuprofen and naproxen.